{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-016850","form_type":"8-K","ticker":"IVF","cik":"0001417926","company_name":"INVO Fertility, Inc.","filed_at":"2025-10-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.357635+00:00","generated_at":"2026-05-17T04:43:58.385999+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"litigation","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"INVO Fertility settles litigation with Dr. Pritts for $6.01M; issues preferred shares","bullets":["Settlement requires Wood Violet to pay Dr. Pritts $6,010,000 in installments through Dec 2026, with $1M already paid.","Remaining payments: $755k due Sep 30, 2025; $755k Dec 31, 2025; $1M Mar 31, 2026; $2M Jun 30, 2026; $500k Dec 31, 2026.","If INVO raises >$2M in any 6-month period, 25% of excess funding accelerates settlement payments.","Institutional investor exercises Additional Investment Right, acquires 400 shares of Series C-2 Preferred for $400k cash, conversion price adjusted to $0.7141.","Settlement terminates all transaction documents, purchase price adjustments, and restrictive covenants; Dr. Pritts released from non-compete."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-016850","json":"https://secwatch.observer/filing/0001493152-25-016850.json","markdown":"https://secwatch.observer/filing/0001493152-25-016850.md","text":"https://secwatch.observer/filing/0001493152-25-016850.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1417926/000149315225016850/0001493152-25-016850-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1417926/000149315225016850/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T04:43:58.385999+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7e847d2d008a57d57fef8e0acf6cfa228972affd","claim":"INVO Fertility, Inc. issued 400 shares of C-2 Preferred of preferred stock to an institutional investor and existing holder for $400,000.","evidence_excerpt":"became a party pursuant to a joinder agreement (the “ Joinder Agreement ”) on October 11, 2024), to acquire 400 shares of C-2 Preferred, with an aggregate stated value of $400,000, for $400,000 in cash. As a result of the exercise, the conversion price on the C-2 Preferred adjusted to $0.7141 per share. The C-2 Preferred issued pursuant to this exercise were","evidence_source":"SEC 8-K Item 3.02/3.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/1417926/000149315225016850/0001493152-25-016850-index.htm","confidence":0.9,"family_label":"Equity Issuances","details":[{"label":"Security","value":"preferred stock"},{"label":"Shares","value":"400 shares of C-2 Preferred"},{"label":"Purchaser","value":"an institutional investor and existing holder"},{"label":"Consideration","value":"$400,000"}],"fact_type":"equity_issuance"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}